C21 preserves endothelial function in the thoracic aorta from DIO mice:role for AT2, Mas and B2 receptors

Autor: Marta Gil-Ortega, Beatriz Somoza, María S. Fernández-Alfonso, Marta Viana, M. Paz Lorenzo, Martín Alcalá, Thomas Unger, Raquel González-Blázquez, William A. Boisvert, Ulrike Muscha Steckelings
Přispěvatelé: Bedrijfsbureau CD, RS: CARIM other
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Receptor
Bradykinin B2

Drug Evaluation
Preclinical

Aorta
Thoracic

Vasodilation
Inbred C57BL
Proto-Oncogene Mas
Receptors
G-Protein-Coupled

Renin-Angiotensin System
Mice
Angiotensin
chemistry.chemical_compound
Bradykinin B2/metabolism
Signal Transduction/drug effects
Receptors
Proto-Oncogene Proteins c-akt/metabolism
Thoracic aorta
Thoracic/drug effects
Endothelial dysfunction
Receptor
Aorta
Vascular/drug effects
Imidazoles/pharmacology
Sulfonamides
Imidazoles
General Medicine
Receptor
Angiotensin
Type 2/agonists

Preclinical
Aorta
Thoracic/drug effects

Signal transduction
Signal Transduction
Type 2/agonists
Agonist
Endothelium
Vascular/drug effects

medicine.medical_specialty
Nitric Oxide Synthase Type III
Sulfonamides/pharmacology
medicine.drug_class
Bradykinin
Thiophenes/pharmacology
Thiophenes
Diet
High-Fat

Nitric Oxide
Cyclic AMP-Dependent Protein Kinases/metabolism
Receptor
Angiotensin
Type 2

Proto-Oncogene Proteins
medicine.artery
Internal medicine
Human Umbilical Vein Endothelial Cells
medicine
Animals
Humans
Endothelium
Obesity
Vascular Diseases
Receptor
Bradykinin B2/metabolism

Protein kinase B
G-Protein-Coupled/metabolism
Vascular Diseases/etiology
Nitric Oxide Synthase Type III/metabolism
Receptor Cross-Talk
Receptors
G-Protein-Coupled/metabolism

Proto-Oncogene Proteins/metabolism
medicine.disease
Cyclic AMP-Dependent Protein Kinases
Diet
Mice
Inbred C57BL

High-Fat
Endocrinology
chemistry
Renin-Angiotensin System/drug effects
Nitric Oxide/metabolism
Drug Evaluation
Endothelium
Vascular

Obesity/complications
Proto-Oncogene Proteins c-akt
Zdroj: González-Blázquez, R, Alcalá, M, Fernández-Alfonso, M S, Steckelings, U M, Lorenzo, M P, Viana, M, Boisvert, W, Unger, T, Ortega, M G & Somoza, B 2021, ' C21 preserves endothelial function in the thoracic aorta from DIO mice : role for AT2, Mas and B2 receptors ', Clinical Science, vol. 135, no. 9, pp. 1145-1163 . https://doi.org/10.1042/CS20210049
Clinical Science, 135(9), 1145-1163. Portland Press Ltd.
ISSN: 0143-5221
DOI: 10.1042/CS20210049
Popis: Compound 21 (C21), a selective agonist of angiotensin II type 2 receptor (AT2R), induces vasodilation through NO release. Since AT2R seems to be overexpressed in obesity, we hypothesize that C21 prevents the development of obesity-related vascular alterations. The main goal of the present study was to assess the effect of C21 on thoracic aorta endothelial function in a model of diet-induced obesity (DIO) and to elucidate the potential cross-talk among AT2R, Mas receptor (MasR) and/or bradykinin type 2 receptor (B2R) in this response. Five-week-old male C57BL6J mice were fed a standard (CHOW) or a high-fat diet (HF) for 6 weeks and treated daily with C21 (1 mg/kg p.o) or vehicle, generating four groups: CHOW-C, CHOW-C21, HF-C, HF-C21. Vascular reactivity experiments were performed in thoracic aorta rings. Human endothelial cells (HECs; EA.hy926) were used to elucidate the signaling pathways, both at receptor and intracellular levels. Arteries from HF mice exhibited increased contractions to Ang II than CHOW mice, effect that was prevented by C21. PD123177, A779 and HOE-140 (AT2R, Mas and B2R antagonists) significantly enhanced Ang II-induced contractions in CHOW but not in HF-C rings, suggesting a lack of functionality of those receptors in obesity. C21 prevented those alterations and favored the formation of AT2R/MasR and MasR/B2R heterodimers. HF mice also exhibited impaired relaxations to acetylcholine (ACh) due to a reduced NO availability. C21 preserved NO release through PKA/p-eNOS and AKT/p-eNOS signaling pathways. In conclusion, C21 favors the interaction among AT2R, MasR and B2R and prevents the development of obesity-induced endothelial dysfunction by stimulating NO release through PKA/p-eNOS and AKT/p-eNOS signaling pathways.
Databáze: OpenAIRE